Use App
AI Agent
Trending
News
Earnings
All
DIA
0.40%
SPY
0.21%
QQQ
0.30%
Trending
SLS
1.74%
RUM
0.39%
TU
0.63%
RDW
0.57%
FUBO
2.38%
ZS
0.08%
ANTHZZX
0.09%
CAPR
0.12%
OMER
6.89%
BIDU
1.75%
Feed
News
Sentiment
Earnings
Fundamentals
Info
Home
Symbol
BCLI
News
Exchange:
OTC
·
Updated 03:58 PM EST
BCLI News
News
all
press releases
BrainStorm Cell Therapeutics Crashes After Hours On Nasdaq Delisting Notice; Retail Sees 'Buy Time'
The company plans to move its shares to the OTCQB market and says the delisting won't impact its ALS research or upcoming Phase 3b trial.
Stocktwits
Full Article
Retail Bulls Cheer FDA Clearance For BrainStorm’s ALS Therapy, But Shares Dip After Hours
BrainStorm Cell Therapeutics plans to enroll 200 ALS patients in its FDA-cleared Phase 3b trial of NurOwn, with a 24-week double-blind phase followed by an open-label extension.
Stocktwits
Full Article
News Movers: Yesterday’s Hottest News That Could Move the Needle Today
Your Only Digest of Market-Moving News and Rumours From High-Growth, Small Cap Stocks
Stocktwits Contributor
Full Article
1
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile